Jan Mattsson - Jan 23, 2023 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Chief Scientific Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Jan 23, 2023
Transactions value $
-$8,629
Form type
4
Date filed
1/23/2023, 04:11 PM
Previous filing
Jan 27, 2023
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$8.63K -197 -0.36% $43.80 54.5K Jan 23, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 35,524 shares of common stock and 18,950 restricted stock units.